Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Lang

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
AIDS (London, England)|December 1, 1996
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study GroupP Hermans, W Rozenbaum, A Jou, et al.
Chemical Communications (Cambridge, England)|May 21, 2020
Resistance to the "last resort" antibiotic colistin: a single-zinc mechanism for phosphointermediate formation in MCR enzymesEmily Lythell, Reynier Suardíaz, Philip Hinchliffe, et al.
Neuroimage. Clinical|November 8, 2014
48 echo T₂ myelin imaging of white matter in first-episode schizophrenia: evidence for aberrant myelinationDonna J M Lang, Eugene Yip, Alexander L MacKay, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2008
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patientsD Rey, B Hoen, P Chavanet, et al.
Nature Chemistry|May 11, 2021
Constructing ion channels from water-soluble α-helical barrelsAlistair J Scott, Ai Niitsu, Huong T Kratochvil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsK T Helzer, M N Sharifi, J M Sperger, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
AIDS (London, England)|December 1, 1996
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study GroupP Hermans, W Rozenbaum, A Jou, et al.
Chemical Communications (Cambridge, England)|May 21, 2020
Resistance to the "last resort" antibiotic colistin: a single-zinc mechanism for phosphointermediate formation in MCR enzymesEmily Lythell, Reynier Suardíaz, Philip Hinchliffe, et al.
Neuroimage. Clinical|November 8, 2014
48 echo T₂ myelin imaging of white matter in first-episode schizophrenia: evidence for aberrant myelinationDonna J M Lang, Eugene Yip, Alexander L MacKay, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2008
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patientsD Rey, B Hoen, P Chavanet, et al.
Nature Chemistry|May 11, 2021
Constructing ion channels from water-soluble α-helical barrelsAlistair J Scott, Ai Niitsu, Huong T Kratochvil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsK T Helzer, M N Sharifi, J M Sperger, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
Pageof 14